Literature DB >> 7622842

Distribution of SPARC in normal and neoplastic human tissue.

P L Porter1, E H Sage, T F Lane, S E Funk, A M Gown.   

Abstract

SPARC (Secreted Protein, Acidic and Rich in Cysteine)/osteonectin is a secreted glycoprotein that exhibits restricted expression in murine adult and embryonic tissues and is associated with cell migration, matrix mineralization, steroid hormone production, cell cycle regulation, and angiogenesis. We produced a monoclonal antibody, MAb SSP2, against a Ca(2+)-binding region of SPARC and evaluated the immunoreactivity of normal and malignant tissue from 118 human samples. In normal tissue we found restricted and moderate reactivity with SSP2 in steroidogenic cells, chondrocytes, placental trophoblasts, vascular smooth muscle cells, and endothelial cells. Strong reactivity was found in fibrocytes and endothelial cells involved in tissue repair and in invasive malignant tumors, including those of the gastrointestinal tract, breast, lung, kidney, adrenal cortex, ovary, and brain. We conclude that SSP2 is a useful reagent for detection of SPARC in human tissue. Given the broad reactivity of malignant tissues, we propose that SPARC expression might contribute to some aspects of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622842     DOI: 10.1177/43.8.7622842

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  46 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

2.  Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.

Authors:  S Blazejewski; B Le Bail; L Boussarie; J F Blanc; L Malaval; K Okubo; J Saric; P Bioulac-Sage; J Rosenbaum
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 3.  SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.

Authors:  Ferda Kaleağasıoğlu; Martin R Berger
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 4.  Angiogenesis in ovarian cancer: molecular pathology and therapeutic strategies.

Authors:  Pamela J Paley
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

5.  Osteonectin influences growth and invasion of pancreatic cancer cells.

Authors:  Ahmed Guweidhi; Jörg Kleeff; Hassan Adwan; Nathalia A Giese; Moritz N Wente; Thomas Giese; Markus W Büchler; Martin R Berger; Helmut Friess
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 6.  Anti-cancer role of SPARC, an inhibitor of adipogenesis.

Authors:  Ganji Purna Chandra Nagaraju; Dipali Sharma
Journal:  Cancer Treat Rev       Date:  2011-01-14       Impact factor: 12.111

7.  Effects of aging and cyclosporin a on collagen turnover in human gingiva.

Authors:  N Gagliano; F Costa; G M Tartaglia; L Pettinari; F Grizzi; C Sforza; N Portinaro; M Gioia; G Annoni
Journal:  Open Dent J       Date:  2009-11-05

8.  Localization of canine brachycephaly using an across breed mapping approach.

Authors:  Danika Bannasch; Amy Young; Jeffrey Myers; Katarina Truvé; Peter Dickinson; Jeffrey Gregg; Ryan Davis; Eric Bongcam-Rudloff; Matthew T Webster; Kerstin Lindblad-Toh; Niels Pedersen
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.

Authors:  Jie Yin; Guowei Chen; Yucun Liu; Si Liu; Pengyuan Wang; Yuanlian Wan; Xin Wang; Jing Zhu; Hongqiao Gao
Journal:  J Exp Clin Cancer Res       Date:  2010-06-02

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.